A Bayesian Method Based on Clotting Factor Activity for the Prediction of Maintenance Warfarin Dosage Regimens

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Therapeutic Drug Monitoring

• Publication date

  2003-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007691-200302000-00005PMID 12548142
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Berichten

  2005cited by this paper
• A comparison of the relative sensitivities of factor VII and prothrombin time measurements in detecting drug interactions with warfarin

  2004cited by this paper
• Validation of an algorithm for oral anticoagulant dosing and appointment scheduling.

  1995cited by this paper
• Stereochemical aspects of warfarin drug interactions: Use of a combined pharmacokinetic‐pharmacodynamic model

  1994cited by this paper
• Pharmacodynamic optimization of warfarin therapy

  1994cited by this paper
• Population pharmacokinetics and pharmacodynamics of warfarin in healthy young adults

  1993cited by this paper
• Prospective comparative study of computer programs used for management of warfarin.

  1993cited by this paper
• A Genetic Algorithm to Improve a Neural Network to Predict a Patient’s Response to Warfarin

  1993cited by this paper
• Method for studying drug‐warfarin interactions

  1993cited by this paper
• Predicting the Daily Prothrombin Time Response to Warfarin

  1990cited by this paper
• BAYESIAN DERIVED PHARMACOKINETIC/PHARMACODYNAMIC VARIABLES FROM WARFARIN THERAPY

  1990cited by this paper
• A simple technique for predicting maintenance dosage of warfarin — Is it better than empirical dosing?

  1989cited by this paper
• Pharmacodynamics of Warfarin at Steady State

  1987cited by this paper
• Effect of using warfarin plasma concentrations in Bayesian forecasting of prothrombin-time response.

  1987cited by this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Warfarin

  1986cited by this paper
• Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states.

  1986cited by this paper
• Enantiomers of warfarin and vitamin K1 metabolism.

  1986cited by this paper
• Bayesian pharmacokinetic/pharmacodynamic forecasting of prothrombin response to warfarin therapy: preliminary evaluation.

  1985cited by this paper
• Stereospecific fluorescence high-performance liquid chromatographic analysis of warfarin and its metabolites in plasma and urine.

  1984cited by this paper
• Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods.

  1982cited by this paper
• Stereoselective Interaction of Sulfinpyrazone with Racemic Warfarin and Its Separated Enantiomorphs in Man

  1982cited by this paper
• Evaluation of a computer‐assisted method for individualized anticoagulation: Retrospective and prospective studies with a pharmacodynamic model

  1982cited by this paper
• Inhibition by warfarin enantiomers of prothrombin synthesis, protein carboxylation, and the regeneration of vitamin K from vitamin K epoxide.

  1981cited by this paper
• Interindividual Differences in the Response to Oral Anticoagulants

  1977cited by this paper
• Multiple-dose kinetics of oral anticoagulants: methods of analysis and optimized dosing.

  1973cited by this paper
• Kinetics of warfarin absorption in man

  1973cited by this paper
• Computer-aided long-term anticoagulation therapy.

  1969cited by this paper

• Semi-empirical Anticoagulation Model (SAM): Dose prediction during warfarin therapy

  2025cites this paper
• Warfarin-A natural anticoagulant: A review of research trends for precision medication.

  2024cites this paper
• Deriving mechanism‐based pharmacodynamic models by reducing quantitative systems pharmacology models: An application to warfarin

  2023cites this paper
• Different risks of hemorrhage in patients with elevated international normalized ratio from chronic liver disease versus warfarin therapy, a population‐based retrospective cohort study

  2022cites this paper
• Evaluation of the predictive performance of Bayesian dosing for warfarin in Chinese patients.

  2019cites this paper
• A factor VII-based method for the prediction of anticoagulant response to warfarin

  2018cites this paper
• The dose individualisation of oral anticoagulants

  2018cites this paper
• Application of pharmacometric methods to understand warfarin dose response

  2018influential citation
• Assessing the relative potency of (S)- and (R)-warfarin with a new PK-PD model, in relation to VKORC1 genotypes

  2017cites this paper
• The Clinical Pharmacokinetics and Pharmacodynamics of Warfarin When Combined with Compound Danshen: A Case Study for Combined Treatment of Coronary Heart Diseases with Atrial Fibrillation

  2017cites this paper
• A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins

  2017cites this paper
• Influence of Genotype on Warfarin Maintenance Dose Predictions Produced Using a Bayesian Dose Individualization Tool

  2016cites this paper
• Methods for Predicting Warfarin Dose Requirements

  2015cites this paper
• Pharmacometric Models for Individualisation of Warfarin in Adults and Children

  2013cites this paper
• Toxicity and teratogenesis in zebrafish embryos (Danio rerio)

  2013cites this paper
• Developmental effects of coumarin and the anticoagulant coumarin derivative warfarin on zebrafish (Danio rerio) embryos.

  2012cites this paper
• A Bayesian Dose-Individualization Method for Warfarin

  2012cites this paper
• Effects of CYP4F2 polymorphism on response to warfarin during induction phase: a prospective, open-label, observational cohort study.

  2012cites this paper
• Pharmacokinetics of intra-articular, intravenous, and intramuscular administration of triamcinolone acetonide and its effect on endogenous plasma hydrocortisone and cortisone concentrations in horses.

  2011cites this paper
• Development of a Bayesian Forecasting Method for Warfarin Dose Individualisation

  2011cites this paper
• A Comprehensive Model for the Humoral Coagulation Network in Humans

  2009cites this paper
• Glucuronidation of Monohydroxylated Warfarin Metabolites by Human Liver Microsomes and Human Recombinant UDP-Glucuronosyltransferases

  2008cites this paper
• A PK–PD Model for Predicting the Impact of Age, CYP2C9, and VKORC1 Genotype on Individualization of Warfarin Therapy

  2007cites this paper
• Pharmacodynamic Model for Warfarin under Thrombo-test Monitoring

  2006cites this paper
• Effect of Herbal Medicines on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects

  2004influential citation
• Pharmacokinetics of intra-articular, intravenous, and intramuscular administration of triamcinolone acetonide and its effect on endogenous plasma hydrocortisone and cortisone concentrations in horses

  year unknowncites this paper
• Pharmacokinetics of intra-articular, intravenous, and intramuscular administration of triamcinolone acetonide and its effect on endogenous plasma hydrocortisone and cortisone concentrations in horses

  year unknowncites this paper